Skip to main content

Abbvie Inc(ABBV-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

AbbVie Inc. ($ABBV) Bullish Structure Calling for More Upside Since July 2023.

Elliott Wave Forecast - Mon Feb 26, 1:21PM CST

Hello Traders. In today’s article, we are going to follow up on AbbVie Inc. (ABBV)  forecast that was posted back in July 2023 and take a look at the latest count. 

$ABBV Daily Elliott Wave View July 2023:

Our remarks from July 2023 were as follows:

"The Daily chart above shows the cycle from April 2022 peak unfold in a double three (WXY) corrective structure. The stock should be at the tail end of the correction towards the Blue Box area at $126.39 – 100.60 where buyers are expected to appear and start the next cycle higher. Although, we like it lower right now towards the blue box, traders should not be short selling the last swing lower as truncations can happen at this stage of the market."

Double Three (WXY) Corrective Structure

$ABBV

$ABBV Latest Elliott Wave View Feb 2024:

$ABBV

The Daily Chart above shows the latest view which ended up seeing the correction end with a truncation before reaching the blue box area. The stock rallied in a 5 wave impulse after finding buyers on 6.28.2023 at $130.96. Once the 5 wave advance ended, a 3 swing pullback (ABC) took place to correct it and was met with buyers. The strong reaction from there has made new ATHs and erased divergence in all timeframes making it the wave 3 of 3 of a nest. The stock is expected to remain supported in a series of 4s and 5s with a target higher towards $186 – 204 before the cycle from June 2023 low ends. Once that cycle ends, we expect the pullback to correct June 2022 to also find buyers again in 3 or 7 swings in the future.

5 Wave Impulse Structure + ABC correction

Source: https://elliottwave-forecast.com/video-blog/abbvie-inc-abbv-bullish-structure-calling-upside-since-july-2023/


On the date of publication, Elliott Wave Forecast did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More from The Globe